{"schema_version":"1.0","type":"article","title":"自免 CAR-T 第一次被迫重算：療效之外，尾端安全風險如何縮小市場？","url":"https://drugnews.com.tw/articles/2026-09-12-autoimmune-car-t-safety-market-reset.html","markdown_url":"https://drugnews.com.tw/articles/2026-09-12-autoimmune-car-t-safety-market-reset.md","lang":"zh-Hant","date":"2026-09-12","publish_at":"2026-09-12T08:00:00+08:00","updated_at":"2026-09-12","category":"商業分析系列","topic":"商業分析系列","tags":["CAR-T","自體免疫","Novartis","Bristol Myers Squibb","細胞治療","安全性"],"summary":"自免 CAR-T 的早期療效不能與尾端免疫安全風險分開計算；市場大小同時取決於病人選擇、長期監測與治療中心承接能力。","key_points":[],"facts":[],"sections":[],"references":[],"images":[{"alt":"圖 1｜免疫重置也要算尾端風險","url":"https://drugnews.com.tw/assets/articles/autoimmune-car-t-safety-market-reset/01_%E5%85%8D%E7%96%AB%E9%87%8D%E7%BD%AE%E8%88%87%E5%B0%BE%E7%AB%AF%E9%A2%A8%E9%9A%AA_typed_v1.png"},{"alt":"圖 2｜自免 CAR-T 是一整條照護路徑","url":"https://drugnews.com.tw/assets/articles/autoimmune-car-t-safety-market-reset/02_%E8%87%AA%E5%85%8DCAR-T%E5%AE%8C%E6%95%B4%E7%85%A7%E8%AD%B7%E8%B7%AF%E5%BE%91_typed_v1.png"},{"alt":"圖 3｜83 人早期資料把療效與風險放在同一帳","url":"https://drugnews.com.tw/assets/articles/autoimmune-car-t-safety-market-reset/03_%E5%85%AB%E5%8D%81%E4%B8%89%E4%BA%BA%E7%99%82%E6%95%88%E9%A2%A8%E9%9A%AA%E5%90%8C%E5%B8%B3_typed_v1.png"},{"alt":"圖 4｜真正產品是治療中心能否安全承接","url":"https://drugnews.com.tw/assets/articles/autoimmune-car-t-safety-market-reset/04_%E6%B2%BB%E7%99%82%E4%B8%AD%E5%BF%83%E8%88%87%E5%8F%B0%E7%81%A3%E4%BA%9E%E6%B4%B2%E6%B1%BA%E7%AD%96_typed_v1.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/autoimmune-car-t-safety-market-reset/01_%E5%85%8D%E7%96%AB%E9%87%8D%E7%BD%AE%E8%88%87%E5%B0%BE%E7%AB%AF%E9%A2%A8%E9%9A%AA_typed_v1.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-09-12）。自免 CAR-T 第一次被迫重算：療效之外，尾端安全風險如何縮小市場？。https://drugnews.com.tw/articles/2026-09-12-autoimmune-car-t-safety-market-reset.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}